• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本传统草药(汉方药)治疗迟发性性腺功能减退症患者的临床疗效。

Clinical efficacy of Japanese traditional herbal medicine (Kampo) in patients with late-onset hypogonadism.

机构信息

Department of Urology, Nagano Red Cross Hospital, Japan.

出版信息

Aging Male. 2010 Sep;13(3):166-73. doi: 10.3109/13685530903536684.

DOI:10.3109/13685530903536684
PMID:20143961
Abstract

INTRODUCTION

In addition to hormone replacement therapy, non-hormonal therapy, particularly Japanese traditional herbal medicine (Kampo), has been used to alleviate the various symptoms of female menopause. The efficacy and safety of Japanese traditional herbal medicine for male late-onset hypogonadism (LOH) are investigated.

METHODS

One hundred fifty-one patients with LOH were treated via the administration of Japanese traditional herbal medicine. The most appropriate Japanese traditional herbal medicine was administered to patients according to their pathogenic alteration. After 4 weeks, the clinical efficacy was evaluated based on improvement of LOH symptoms and the score of the simplified menopausal index (SMI). Additionally, predictive factors of efficacy of Japanese traditional herbal medicine were analyzed.

RESULTS

Among 151 patients with LOH, 63 (41.8%) achieved both relief from LOH symptoms and normalized SMI score (Excellent response group), whereas 44 (29.1%) achieved either relief from LOH symptoms or normalized SMI score (Fair). However, 44 (29.1%) patients displayed neither relief from LOH symptoms nor normalized SMI score (Poor). Adverse reactions were observed only in four (2.6%) patients. Patients displaying excess conditions and mild LOH symptoms appeared to be superior candidates for Japanese traditional herbal medicine.

CONCLUSION

Japanese traditional herbal medicine is an effective and safe treatment for LOH.

摘要

简介

除激素替代疗法外,非激素疗法,特别是日本传统草药(汉方药),已被用于缓解女性更年期的各种症状。本研究旨在探讨日本传统草药治疗男性迟发性性腺功能减退症(LOH)的疗效和安全性。

方法

151 例 LOH 患者接受日本传统草药治疗。根据患者的病因变化,为患者选择最合适的日本传统草药。4 周后,根据 LOH 症状改善和简化绝经指数(SMI)评分评估临床疗效。此外,还分析了日本传统草药疗效的预测因素。

结果

在 151 例 LOH 患者中,63 例(41.8%)既缓解了 LOH 症状,又使 SMI 评分正常(优效组),44 例(29.1%)缓解了 LOH 症状或 SMI 评分正常(中效)。然而,44 例(29.1%)患者既未缓解 LOH 症状,也未使 SMI 评分正常(差)。仅 4 例(2.6%)患者出现不良反应。表现为实证和轻度 LOH 症状的患者似乎更适合接受日本传统草药治疗。

结论

日本传统草药是治疗 LOH 的一种有效且安全的方法。

相似文献

1
Clinical efficacy of Japanese traditional herbal medicine (Kampo) in patients with late-onset hypogonadism.日本传统草药(汉方药)治疗迟发性性腺功能减退症患者的临床疗效。
Aging Male. 2010 Sep;13(3):166-73. doi: 10.3109/13685530903536684.
2
Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.睾酮软膏替代疗法可缓解迟发性性腺功能减退症患者的下尿路症状。
Aging Male. 2010 Dec;13(4):242-6. doi: 10.3109/13685538.2010.487552. Epub 2010 Aug 26.
3
Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.赛鸽口服液或睾丸素治疗迟发性性腺功能减退症患者后细胞因子水平的变化。
Aging Male. 2011 Mar;14(1):76-81. doi: 10.3109/13685538.2010.502268. Epub 2010 Aug 16.
4
A Kampo formula, saikokaryukotsuboreito, improves serum testosterone levels of castrated mice and its possible mechanism.一种汉方药,柴芍六君子汤,可改善去势小鼠的血清睾酮水平及其可能机制。
Aging Male. 2013 Mar;16(1):17-21. doi: 10.3109/13685538.2012.755507. Epub 2013 Jan 22.
5
Diet and Japanese herbal medicine for recalcitrant atopic dermatitis: efficacy and safety.饮食与日本草药治疗顽固性特应性皮炎:疗效与安全性
Drugs Exp Clin Res. 2004;30(5-6):197-202.
6
[The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].[根据迟发性性腺功能减退(LOH)严重程度,睾酮软膏(Glowmin)治疗LOH患者的疗效]
Hinyokika Kiyo. 2007 Jan;53(1):25-9; discussion 29.
7
Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.男性迟发性性腺功能减退的睾酮替代疗法:可用的药物治疗策略。
J Endocrinol Invest. 2005;28(11 Suppl Proceedings):61-8.
8
[Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].[男性迟发性性腺功能减退:疾病实体尚不明确及对睾酮治疗的保留意见]
Ned Tijdschr Geneeskd. 2006 Sep 2;150(35):1925-8.
9
Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.睾酮治疗可改善与迟发性性腺功能减退相关的男性代谢综合征患者对传统治疗的临床反应。
Minerva Endocrinol. 2008 Sep;33(3):159-67.
10
ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.国际男性性医学会(ISA)、国际男性性医学和男性学学会(ISSAM)以及欧洲泌尿外科学会(EAU)关于男性迟发性性腺功能减退的调查、治疗和监测的建议:科学背景与理论依据。
Aging Male. 2005 Jun;8(2):59-74. doi: 10.1080/13685530500163416.

引用本文的文献

1
Late-onset hypogonadism: current methods of clinical diagnosis and treatment in Japan.迟发性性腺功能减退:日本目前的临床诊断与治疗方法
Asian J Androl. 2025 Jul 1;27(4):447-453. doi: 10.4103/aja2024111. Epub 2025 Jan 28.
2
Efficacy of keishibukuryogan for hot flashes in prostate cancer patients receiving androgen deprivation therapy: a sub-analysis focusing on hormonal and cytokine levels.桂枝茯苓丸对接受雄激素剥夺治疗的前列腺癌患者潮热的疗效:一项聚焦于激素和细胞因子水平的亚分析
Transl Androl Urol. 2023 Aug 31;12(8):1273-1282. doi: 10.21037/tau-23-121. Epub 2023 Aug 28.
3
Efficacy and Safety of Maca () in Patients with Symptoms of Late-Onset Hypogonadism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
玛卡()对迟发性性腺功能减退症状患者的疗效与安全性:一项随机、双盲、安慰剂对照临床试验
World J Mens Health. 2023 Jul;41(3):692-700. doi: 10.5534/wjmh.220112. Epub 2023 Jan 1.
4
Clinical efficiency of combination therapy using testosterone replacement therapy, phosphodiesterase 5 inhibitors and Kampo herbal medicine for eugonadal patients with late-onset hypogonadism syndrome.睾酮替代疗法、磷酸二酯酶5抑制剂与汉方草药联合治疗性腺功能正常的迟发性性腺功能减退综合征患者的临床疗效
Exp Ther Med. 2021 Oct;22(4):1173. doi: 10.3892/etm.2021.10608. Epub 2021 Aug 13.
5
Environmental Factors-Induced Oxidative Stress: Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction.环境因素诱导的氧化应激:性腺功能减退和勃起功能障碍中的激素及分子途径紊乱
Antioxidants (Basel). 2021 May 24;10(6):837. doi: 10.3390/antiox10060837.
6
Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation therapy.日本传统汉方制剂桂枝茯苓丸对接受雄激素剥夺治疗的前列腺癌患者潮热的疗效及安全性。
Transl Androl Urol. 2020 Dec;9(6):2533-2540. doi: 10.21037/tau-20-901.
7
Effect of Korean Herbal Formula (Modified Ojayeonjonghwan) on Androgen Receptor Expression in an Aging Rat Model of Late Onset Hypogonadism.韩国草药配方(改良五子衍宗丸)对迟发性性腺功能减退衰老大鼠模型雄激素受体表达的影响。
World J Mens Health. 2019 Jan;37(1):105-112. doi: 10.5534/wjmh.180051.
8
Antioxidant and Antifibrotic Effect of a Herbal Formulation and in the Experimental Andropause via Nrf2/HO-1 Signaling Pathway.草药配方通过 Nrf2/HO-1 信号通路对实验性更年期的抗氧化和抗纤维化作用。
Oxid Med Cell Longev. 2017;2017:6024839. doi: 10.1155/2017/6024839. Epub 2017 Sep 17.
9
Effects of Saikokaryukotsuboreito on Spermatogenesis and Fertility in Aging Male Mice.柴胡龙骨牡蛎汤对衰老雄性小鼠精子发生及生育能力的影响
Chin Med J (Engl). 2016 Apr 5;129(7):846-53. doi: 10.4103/0366-6999.178972.
10
Phytotherapy: emerging therapeutic option in urologic disease.植物疗法:泌尿系统疾病中新兴的治疗选择。
Transl Androl Urol. 2012 Sep;1(3):181-91. doi: 10.3978/j.issn.2223-4683.2012.05.10.